Lenvatinib is a multi-target drug that is different from other tyrosine kinase inhibitors (TKIs). It is currently approved for liver cancer, thyroid cancer and renal cancer. It is a new targeted drug for the treatment of liver cancer.
You can check Lenvatinib cost here- https://www.medixocentre.com/l....envatinib-lenvima-co
